Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nitrosamine mitigation: NDMA impurity formation and its inhibition in metformin hydrochloride tablets.
Shakleya D, Alayoubi A, Brown D, Mokbel A, Abrigo N, Mohammad A, Wang J, Li D, Shaklah M, Alsharif FM, Desai S, Essandoh M, Faustino PJ, Ashraf M, O' Connor T, Vera M, Raw A, Sayeed VA, Keire D. Shakleya D, et al. Among authors: keire d. Int J Pharm. 2024 Dec 5;666:124832. doi: 10.1016/j.ijpharm.2024.124832. Epub 2024 Oct 14. Int J Pharm. 2024. PMID: 39414182
Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets.
Shakleya D, Asmelash B, Alayoubi A, Abrigo N, Mohammad A, Wang J, Zhang J, Yang J, Marzan TA, Li D, Shaklah M, Alsharif FM, Desai S, Faustino PJ, Ashraf M, O'Connor T, Vera M, Raw A, Sayeed VA, Keire D. Shakleya D, et al. Among authors: keire d. J Pharm Sci. 2023 Dec;112(12):3075-3087. doi: 10.1016/j.xphs.2023.06.013. Epub 2023 Jun 24. J Pharm Sci. 2023. PMID: 37364772
Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug Substances.
Lu D, Rege B, Raw A, Yang J, Alam K, Bode C, Zhao L, Faustino P, Wu F, Shakleya D, Nickum E, Li BV, Wang R, Stier E, Miezeiewski B, Patel R, Boam A, Lionberger R, Keire D, Yu L. Lu D, et al. Among authors: keire d. J Pharm Sci. 2024 Sep;113(9):2708-2714. doi: 10.1016/j.xphs.2024.05.033. Epub 2024 Jun 9. J Pharm Sci. 2024. PMID: 38862090
Optimizing the detection of N-nitrosamine mutagenicity in the Ames test.
Heflich RH, Bishop ME, Mittelstaedt RA, Yan J, Guerrero SK, Sims AM, Mitchell K, Moore N, Li X, Mei N, Elespuru RK, King ST, Keire DA, Kruhlak NL, Dorsam RT, Raw AS, Davis Bruno KL, McGovern TJ, Atrakchi AH. Heflich RH, et al. Among authors: keire da. Regul Toxicol Pharmacol. 2024 Nov;153:105709. doi: 10.1016/j.yrtph.2024.105709. Epub 2024 Sep 28. Regul Toxicol Pharmacol. 2024. PMID: 39343352
Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assays.
Li X, Le Y, Seo JE, Guo X, Li Y, Chen S, Mittelstaedt RA, Moore N, Guerrero S, Sims A, King ST, Atrakchi AH, McGovern TJ, Davis-Bruno KL, Keire DA, Elespuru RK, Heflich RH, Mei N. Li X, et al. Among authors: keire da. Regul Toxicol Pharmacol. 2023 Jun;141:105410. doi: 10.1016/j.yrtph.2023.105410. Epub 2023 May 18. Regul Toxicol Pharmacol. 2023. PMID: 37210026 Free PMC article.
123 results